Previous Close | 937.61 |
Open | 926.94 |
Bid | 956.86 x 100 |
Ask | 958.17 x 100 |
Day's Range | 926.94 - 958.02 |
52 Week Range | 684.81 - 998.33 |
Volume | |
Avg. Volume | 472,840 |
Market Cap | 105.448B |
Beta (5Y Monthly) | 0.14 |
PE Ratio (TTM) | 27.52 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
Regeneron Pharmaceuticals ( NASDAQ:REGN ) First Quarter 2024 Results Key Financial Results Revenue: US$3.15b (flat on...
Discover how Regeneron sustains robust growth with significant advancements in clinical programs and strategic market maneuvers.